Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ismail Oguz Kara"'
Autor:
Mehmet Ali Kazgı, Ertugrul Bayram, Tolga Kosecı, Burak Mete, Tugba Toyran, Melek Ergin, Ismail Oguz Kara
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 1014 (2024)
(1) Background: The introduction of novel therapies has led to a considerable evolution in the management of Multiple Myeloma, and chromosomal abnormalities predict the success of treatment. We aimed to characterize cytogenetic abnormalities for risk
Externí odkaz:
https://doaj.org/article/27754a4c12e04bceb6e94506829312d4
Autor:
Faysal Dane, Kirhan Ozgurdal, Şuayib Yalçın, Mustafa Benekli, Nuri Faruk Aykan, İdris Yücel, Metin Özkan, Turkkan Evrensel, Alper Sevinç, Hasan Şenol Coskun, Ulus Ali Sanli, Ismail Oguz Kara, Perran Fulden Yumuk
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
ObjectivesRegorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD evaluated the safety and efficacy
Externí odkaz:
https://doaj.org/article/b3153538a6d44e7c98c28e54c95923dd
Publikováno v:
Croatian Medical Journal. 63:461-474
To evaluate the inhibitory effects of ornidazole on the proliferation and migration of metastatic melanoma cell line (B16F10) in vitro and its anti-cancer effects in vivo using a melanoma mouse model.We investigated the effects of ornidazole on cell
Autor:
Alper Sevinc, Mustafa Benekli, Hasan Şenol Coşkun, Kirhan Ozgurdal, Suayib Yalcin, Metin Ozkan, Turkkan Evrensel, Perran Fulden Yumuk, Nuri Faruk Aykan, Faysal Dane, Ismail Oguz Kara, Ulus Ali Sanli, Idris Yucel
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
BMJ Open
BMJ Open
Objectives Regorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD evaluated the safety and efficacy
WOS: 000493372200002 PubMed ID: 31709947 Introduction: Mesothelioma is an aggressive tumour that originates in serous surfaces. The primary end point of this study was to invastigate the relationship of progression free survival (PFS) and overall sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8ff944e40f532a6714cfb8c2389e30
https://hdl.handle.net/20.500.12605/9104
https://hdl.handle.net/20.500.12605/9104
Autor:
Berna Bozkurt Duman, Meral Gunaldi, Ufuk Tatli, Berksoy Sahin, Cigdem Usul Afsar, Ismail Oguz Kara
Publikováno v:
Oncology Letters. 10:439-442
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe bone disease for which the pathogenetic mechanisms and risk factors are not fully understood. The present study evaluated the data of 652 patients with bone metastasis that had unde
Autor:
Ata Secilmis, Berksoy Sahin, Berna Bozkurt Duman, Abdullah Tuli, Meral Gunaldi, Cigdem Usul Afsar, Vehbi Ercolak, Ismail Oguz Kara, Semra Paydas, Melek Erkisi
Publikováno v:
International Journal of Hematology and Oncology. 24:157-162
In this study we investigated the role of the polymorphic types of CYP2D6 in the Turkish population for therapeutic efficacy among patients with early stage breast cancer who treated with tamoxifen. CYP2D6 plays an important role in tamoxifen metabol
Publikováno v:
Onkologie. 35:694-697
PubMedID: 23147547 Background: Myeloid sarcoma rarely presents in the absence of systemic myeloid disease. Case Report: In this study, we present a case of intracerebral myeloid sarcoma with no diagnosis of any hematological disease in a 22-year-old
Publikováno v:
Archives of Gynecology and Obstetrics. 283:1363-1368
PubMedID: 21298439 Introduction: Malignant mixed Müllerian tumor (MMMT) of the ovary is a rare and highly aggressive tumor. It accounts
Publikováno v:
International Journal of Clinical Practice. 62:1206-1211
Summary Aim: There are more than 350 million people worldwide chronically infected with hepatitis B virus (HBV), who are at high risk for the development of hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Because of the conflicting results a